Industrial demand surges 11.2% as data center tariff realigns infrastructure costs.

Operating profit jumped 14% on margin expansion and cost discipline.

Fee-earning AUM surged 32% year-over-year to $48.9 billion amid strong fundraising momentum.

Record aftersales profit and 12% share reduction drive stable earnings growth.

Net sales rose 31% year over year on acquisitions and retardant volume growth.

New 3870 pump production ramp compressed margins but bookings doubled shipments.

Aerospace demand and customer engagement lifted record revenue and margins.

Newell returns to sales growth for first time in four years, raising full-year guidance.

Net sales rose 5.2% as adjusted EPS jumped 53% on wholesale strength.

CEO Rousseau discusses specialty pharmacy expansion and integration of recent acquisitions.

Record revenue and surging options volume drive strong momentum.

Uranium prices hit decade highs as nuclear demand accelerates globally.

Record $1.89 trillion AUM offset by equity outflows and fee pressure.

Net loss improved 5% on international partnerships and manufacturing gains.

Record net income drove 27.9% return on equity, beating industry average.

Net cash position surged to $991 million as gold prices climbed.

Dodig outlines dividend reset and $2.7B debt reduction plan amid digital headwinds.

Revenue hit record $8.5B with 21% growth as data center demand surges 65% organically.

Organic sales grew 5.8% on volume gains and market share expansion across core brands.

Net income jumped $1.24 billion on higher commodity prices.

Record returns and upgraded guidance after Evelyn Partners acquisition.

Adjusted EPS jumped 29% as operational excellence and tariff benefits expanded margins.

Rate base growth and Arizona weather drove earnings gains despite regulatory lag.

Record pretax earnings and margin expansion offset SBA exit headwinds.

EPOS integration exceeded expectations as cost cuts offset soft international demand.

Record EPS and margins drive grid expansion strategy amid strong order intake.

CEO Collins discusses ATM equity program and portfolio expansion.

Production exceeded guidance while net cash surged to $566 million post-asset sale.

Core EPS steady as net interest margin expands post-Flushing deal.

Steelcase integration drives 14% EPS growth as workplace demand strengthens.

VCM plant outage cost $40 million, but adjusted EBITDA rose on pricing gains.

Fintech lending drives record profitability as EPS surges 14.2% and guidance climbs.

Record EBITDA and 28% EPS growth despite margin pressure from raw material costs.

Chemical Intermediates surged 39% as revenue climbed 10% despite Fibers decline.

Food Safety segment drives 4.3% core growth as company executes transformation strategy.

Industrial PPE surges 16% organically as connected safety solutions gain traction.

Billing delays pressured margins, though acquisitions drove anatomic pathology growth.

Net sales hit $3.0 billion as pricing and volume gains offset inflationary pressures.

Crocs brand surpasses $1 billion in quarterly revenue for the first time.

Record $1B revenue as pharma growth offsets margin pressure.

FFO guidance raised as occupancy and leasing spreads drive outperformance.

Two major growth projects advance toward production as CEO prepares transition.

Record backlog of $21.4 billion fuels guidance hikes across power delivery and clean energy.

Revenue beat guidance while operating margins expanded 142 basis points year over year.

Record volumes and international growth propelled second-quarter revenue to $558.9 million.

China sales surged 9% as laboratory demand accelerated, lifting full-year guidance.

Utility transitions to pure-play model after $1.7B water sale, reaffirms growth guidance.

Revenue surged 150% as metal sales ramped and cash flow tripled.

Patent expiration pressures revenue as FMC pursues $1 billion debt reduction through asset sales.

Revenue hit $3.1 billion as operating margins expanded for ninth straight quarter.

Lumber pricing gains offset housing weakness as company reduces debt.

Revenue hit $103.5 million, up 20% YoY, as TissueCypher surged 63%.

Battery materials hit first profit in nine quarters as Argentina lithium operations surge.

CEO Jared Wolff discusses balance sheet restructuring and path to double-digit returns.

Record $911.6 billion in managed assets driven by equity gains and strategic acquisitions.

Operating EPS surged 45% as annuity collections hit record levels.

July order momentum accelerates as long-cycle projects convert ahead of guidance raise.